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Abstract In most cell types sphingomyelin is synthesized pre- 
dominantly in the cis-medial compartments of the Golgi stacks 
whereas the contribution of the plasma membrane is much lower. 
The aim of this study was to assess the contribution of both 
compartments to the synthesis of sphingomyelin in myelinating 
cells. Therefore, oligodendroeytes from rat spinal cord were incu- 
bated in culture with fluorescently- or radiolabelled ceramides, 
and the effects of a block in the vesicular flow (monensin, bre- 
feldin A, low temperature) on surface synthesis of sphingomyelin 
were evaluated. The results indicate that = 50% of the sphingomy- 
elin synthase is present at the plasma and myelin membranes of 
oligodendrocytes. 
Key words: Sphingomyelin biosynthesis; Myelin; N-Lissamine 
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1. Introduction 
Oligodendrocytes are the cells that assemble the huge 
amounts of myelin membrane to enwrap and insulate the axons 
in the central nervous system [1,2]. Primary cultures of oli- 
godendrocytes offer an attractive model system to investigate 
the metabolism and intracellular routing of ceramide deriva- 
tives to the myelin membrane which is enriched in sphingolip- 
ids. 
Mammalian cells generally synthesize sphingomyelin (SM) 
predominantly at the cis-medial Golgi stacks [3,4], but contribu- 
tions by the plasma membrane [5,6] and of the endocytic recy- 
cling pathway [7] have been reported as well. Oligodendrocytes 
have an intricate network of processes and a very large mem- 
brane surface area [2]. Therefore, we wanted to evaluate the 
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relative activity of SM synthase at the plasma nd myelin mem- 
branes. 
In vivo studies [8,9] have provided indirect evidence that the 
production of SM occurs at the plasma and/or myelin mem- 
branes of myelinating cells. Analysis of radiolabel from lipid 
precursors injected in the sciatic nerves of rats led Boiron et al. 
[8] to conclude that the plasma membrane of a Schwann cell, 
which is the functional analog of the oligodendrocyte in the 
peripheral nervous system, might be a site of SM synthesis. 
Furthermore, from the distribution pattern of C6-NBD-Cer, 
injected into the ventricles of rat brain, Di Biasi et al. [9] esti- 
mated that approx, equal amounts of SM were synthesized at 
the plasma membrane and the Golgi apparatus of oligodendro- 
cytes. 
Sphingomyelin turnover at the plasma membrane is part of 
signalling pathways in a variety of cell types [10], including cells 
of neuronal origin [11]. This putative SM cycle, probably oper- 
ating at the cytosolic face of the plasma membrane [12], could 
have important implications for the regulation of oligodendro- 
cyte differentiation. The suggestion of a high capacity for SM 
synthesis at the plasma membrane of myelin producing cells 
[8,9] and the potential importance of SM in signalling events 
during myelination, prompted us to investigate the assembly of 
SM at the plasma membrane of rat spinal cord oligodendro- 
cytes in culture. 
2. Experimental 
2.1. Materials 
UDP-glucose, D-erythro-sphingosine, monensin, D,L-~-hy- 
droxycaproic a id (2-hydroxyhexanoic acid), [1-14C]hexanoic acid and 
brefeldin A were purchased from Sigma (St. Louis, USA), D-erythro-[3- 
3H]sphingosine from DuPont NEN (USA) and C6-NBD-Cer from Mo- 
lecular Probes (Eugene, USA). C6-NBD-labelled lipid reference com- 
pounds for high-performance thin-layer chromatography (HPTLC) 
were kindly provided by Dr. G. Van Meer (Medical School, Utrecht 
University, The Netherlands). C~2-Lrh-lipids were synthesized at the 
department of Prof.Dr. S. Marchesini (Brescia, Italy; [13]) and radiola- 
belled ceramides as described elsewhere (Van der Bijl, P. et al., manu- 
script submitted): C6-[14C]-Cer by N-coupling the sphingosine base to 
[1J4C]hexanoic a id; C6-(D-~OH)-[3H]-Cer by N-coupling [3H]sphingo- 
sine to D,L-2-hydroxyhexanoic ac d and separation ofthe stereoisomers 
by TLC (Merck, Darmstadt, Germany). 
2.2. Cell culture and incubation with labelled ceramides 
Oligodendrocyte-enriched cultures derived from spinal cords of l- 
week-old Wistar rat pups were prepared according to [14]. After one 
day the cultures were shifted to chemically-defined medium (CDM). 
Experiments were carried out after four days in culture. 
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C~2-Lrh-Cer or C6-NBD-Cer were incorporated into small unilamel- 
lar egg-PC vesicles (SUV) [15]. Alternatively, labelled ceramides were 
complexed with BSA immediately before use [16]. Ethanol solutions of 
C~2-LRh-Cer were prepared by dissolving the required amount of dried 
C,2-LRh-Cer in 70% (v/v) ethanol to a final concentration f 100 raM. 
The labelled ceramides (SUV, BSA-complex or ethanol solution) 
were diluted to a final concentration f 20 nmol Cer/106 cells: (i) for long 
term incubations (2448 h with SUV): in CDM devoid of BSA; (ii) for 
short term incubations (3 h): in HBSS/I% (w/v) defatted BSA/20 mM 
glucose/10 mM Hepes, pH 7.4. Lipid extraction from the cells and 
medium, separation by HPTLC, lipid extraction from the silica and 
fluorometry of the fluorescent lipids were performed as described [15]. 
Incubations were carried out in triplicate. Representative experiments 
(n -> 2) are shown. 
2.3. Purification of myelin and assays for sphingolipid synthesizing 
enzymes 
Myelin was isolated from adult rat brain according to Norton [17]. 
The crude myelin fraction was subjected to osmotic shocks in distilled 
water to increase myelin purity and to minimize axolemmal contamina- 
tion. Myelin purity was determined by measuring the activity of 2'3'- 
cyclic nucleotide 3'-phosphodiesterase (CNPase). The samples were 
activated [14] before determining CNPase activity according to [18]. 
Protein was determined with BSA as standard [19]. 
SM synthase and UDP-glucose : ceramide glucosyltransferase ctivi- 
ties were measured in the same assay system, essentially according to 
[20]. Briefly, the standard assay mixture (0.5 ml) consisted of 50 mM 
HEPES-Na (pH 7.4), 5 mM EDTA, 26/zM C6-NBD-Cer/174/zM egg 
phosphatidylcholine SUV, 5 mM MnC12, 500 ,uM UDP-glucose and 
50-200/zg of cellular protein. The enzyme reaction was carried out for 
30 min at 37°C. Then 1.6 ml of chloroform/methanol (1:2, v/v) was 
added to the mixture and lipids were extracted by adding 0.5 ml chloro- 
form and 0.5 ml 0.88% (w/v) KCI/10 mM acetic acid. The NBD-labelled 
sphingolipids were separated by HPTLC and quantified [15]. 
3. Results and discussion 
3.1. Studies with cells in culture 
Fig. 1 shows that the accumulation of C~2-LRh-SM was 
arrested upon withdrawal of the fluorescent substrate (egg-PC 
vesicles containing Cj2-LRh-Cer) from the medium after a 24 
h incubation period. This could result from: (i) a lack of sub- 
strate(s); or (ii) limited access of the residual fluorescent cer- 
amide to SM synthase. Option (i) is unlikely, because we have 
demonstrated previously that only a small fraction of the cell- 
associated C~2-LRh-Cer is metabolized [15] and the intracellu- 
lar level of CI2-LRh-Cer decreased but slightly (<20%) during 
the chase period (results not shown). Moreover, inspection by 
confocal scanning laser microscopy showed that the perinu- 
clear region where the Golgi apparatus is situated was labelled 
intensely already after 3 h of incubation with C~2-LRh-Cer SUV 
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Fig. 1. The production of Cu-LRh-SM in oligodendrocytes in primary 
culture. Cells were incubated with C~2-LRh-Cer containing vesicles (20 
nmol/106 cells) for 24 h. Thereafter, the cultures were washed twice with 
HBSS and incubated in medium with (e) or without (©) the C~2-LRh- 
Cer containing vesicles for another 24 h at 37°C. The values represent 
the total amount of C~2-LRh-SM recovered (from the cells + medium). 
Data (means + S.E.M.) of a typical experiment (n = 2) are shown. 
(cf. [22]). At this time point, cell-associated fluorescence 
amounts to approx. 1.3 nmol/106 cells, and only a small fraction 
of this (<3%) has been metabolized. Thereafter, products are 
formed at a higher rate and after 24 h of labelling, the cell- 
associated fluorescence is approx. 8 nmol/106 cells, of which 
maximally 1 nmol cells can be attributed to C~2-LRh-meta- 
bolites [15]. 
Therefore, we feel confident hat the intracellular CI2-LRh- 
Cer concentration is not limiting C~2-LRh-SM synthesis. On the 
other hand, if the major part of C12-LRh-SM is synthesized at 
the plasma membrane C~2-LRh-SM synthesis could be arrested 
because the egg-PC present in the SUV is a major phospho- 
choline donor for SM synthesis at the plasma membrane. This 
possibility was discarded, because the rate of C~2-LRh-SM syn- 
thesis was the same whether Cl2-LRh-Cer was added to oli- 
godendrocytes a lipid monomers or incorporated into egg-PC 
containing SUV. Hence, the most plausible explanation for the 
Table 1 
Effect of monensin and brefeldin A on SM synthesis in cultured oligodendrocytes 
Incubation 
conditions 
Recovery of C12-LRh-SM in Recovery of C6-NBD-SM in 
Medium j Cells 2 Total Medium ~ Cells 2 Total 
Control 180 _+ 15 11.1 _+ 0.9 191 1125 _+ 50 96 4- 3 1221 
+ Monensin 181 4- 18 11.4 4- 1.I 192 1063 _+ 73 174 _+ 3 1247 
+ BFA 194 _+ 32 19.0 _+ 0.1 214 895 4- 35 387 + 16 1282 
Oligodendrocytes at 4 DIC were incubated (3 h at 37°C) with BSA-complexes ofeither Cl2-LRh-Cer or C6-NBD-Cer with or without monensin (0.5 
pM) or BFA (l.0/ag/ml). The cells were preincubated with these drugs for l0 min or 30 min, respectively. Labelled lipids were extracted from the 
outer leaflet of the plasma membrane by a back-exchange procedure: Incubation of the cells for 15 rain at 4°(2 with 1% (w/v) BSA in HBSS, followed 
by washing with HBSS. This procedure was performed twice. Control experiments indicated that back-exchanging twice was sufficient o deplete 
the plasma membrane because no additional labelled lipids could be extracted uring a third back-exchange. Data represent the amount of fluorescent 
SM extracted and are expressed as pmol/106 cells. Values (means _+ S.E.M.) of a representative experiment (n = 2) are shown. 
Labelled SM recovered from the incubation medium and back-exchange medium which were pooled prior to the lipid extraction. 
2 Labelled SM recovered from the cells after the back-exchange procedure. 
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Table 2 
Distribution of labelled SM in oligodendrocytes after incubation at low 
temperature 
Ceramide precursor SM synthesized at the plasma membrane (%) 
CI2-LRh-Cer 99.0 _+ 9.9 
C6-NBD-Cer 55.4 +_ 4.9 
C6-[t4C]-Cer 48.8 +- 2.8 
C6-(D-c~OH)-[3H]-Cer 52.0 + 2.6 
Oligodendrocytes at 4DIC were incubated with labelled ceramide com- 
plexed to BSA. Labelled ceramides were added to cultured oligoden- 
drocytes in the following concentrations: CI -LRh-Cer and C6-NBD- 
Cer (5.0/IM), C6-[14C]-Cer (7.5//M; 297 Bq/nmol) and C6-(D-~OH )- 
[3H]-Cer (60 nM; 0.2 Bq/nmol). After the incubation for 3 h at 10°C, 
the outer leaflet of the plasma membrane was depleted by back-ex- 
change (see legend to Table 1). The percentage of plasma membrane 
synthesis was calculated by dividing the amount of labelled SM recov- 
ered from the combined incubation and back-exchange m dia by the 
total amount of labelled SM (media + cells). Values are means 
+ S.E.M. of triplicate incubations ina representative experiment (with 
C~2-LRh-Cer and C6-NBD-Cer, n = 6; with C6-[14C]-Cer and C6-(D" 
o~OH)-[3H]-Cer, n = 2). 
observed arrest in C~2-LRh-SM synthesis i that C~2-LRh-SM 
is predominantly s nthesized at the plasma membrane. Thus, 
after the removal of the exogenous Cl2-LRh-Cer, the substrate 
for C~2-LRh-SM synthesis i no longer available and as a con- 
sequence Cj2-LRh-SM does not accumulate any more. 
Parenthetically, wenote that the appearance ofC~2-LRh-SM 
in the medium is not due to the operation of SM synthase in 
membrane fragments shredded into the medium by the cultured 
cells. This was verified by control incubations of C12-LRh-Cer 
in culture medium that had been exposed to oligodendrocytes. 
3.2. Effects of monensin, brefeldin A and low temperature 
incubation 
To further discriminate between SM synthesis at the plasma 
membrane and in the Golgi apparatus we carried out incuba- 
tions under conditions that block transport of SM, generally 
considered to be vesicular [23], from the Golgi system to the 
plasma membrane. Two inhibitors were used: (i) monensin, 
which inhibits transport of glycoproteins between medial- and 
trans- regions of the Golgi apparatus [24] and blocks the ap- 
pearance of newly synthesized sphingolipids at the plasma 
membrane (see [23] for references) without inhibiting SM syn- 
thesis from a fluorescent ceramide precursor [25]; (ii) the fungal 
metabolite brefeldin A (BFA) that causes areversible disassem- 
bly of the Golgi apparatus and inhibits vesicular protein trans- 
port along the exocytotic pathway towards the plasma mem- 
brane [26,27]. In addition, we carried out incubations at 10°C, 
a temperature that does not allow vesicular transport of pro- 
teins and also blocks sphingolipid transport [25,28]. 
Table 1 shows that monensin had no and BFA very little 
effect on C12-LRh-SM synthesis or C12-LRh-SM distribution 
over cells and medium in 3 h incubations. In contrast, both 
drugs considerably altered the distribution of C6-NBD-SM 
(Table 1). The different behaviour of the two fluorescent probes 
can be rationalized: C6-NBD-Cer associates to the plasma 
membrane of oligodendrocytes, followed by spontaneous bi- 
layer transfer and entry into the cells via monomeric diffusion. 
Consequently, C6-NBD-Cer becomes rapidly accessible to SM 
synthase in the Golgi lumen [25]. On the other hand, C~2-LRh- 
Cer has a longer acyl-chain and a more bulky fluorophore than 
C6-NBD-Cer. Importantly, because the half-time for spontane- 
ous lipid movement increases with the chain-length of the acyl- 
spacer linking the fluorophore to sphingosine [29]. Therefore, 
we consider it likely that C~2-LRh-Cer associates with the outer 
leaflet of the plasma membrane and cannot reach the luminal 
face of the Golgi-apparatus a  efficiently as C6-NBD-Cer dur- 
ing a 3 h incubation. For this reason we postulate that C~2-LRh- 
SM is produced predominantly at the plasma membrane; spe- 
cially during short-term incubations. 
This notion is supported by the observed lag time and slow 
rate of glycosphingolipid synthesis with C~2-LRh-Cer as sub- 
strate (in contrast to C6-NBD-Cer) [15]. Also, our observation 
that monensin and BFA affect C6-NBD-SM metabolism and 
transport less in oligodendrocytes han in other cell types, is in 
agreement with the above hypothesis. 
In order to determine the relative contribution of the plasma 
membrane to the over-all synthesis of SM, several abelled 
ceramides were incubated with oligodendrocytes at 10°C fol- 
lowed by a back-exchange procedure. Because at 10°C vesicu- 
lar transport isarrested [28], the amount of labelled SM recov- 
ered from the incubation medium should reflect the amount of 
Table 3 
Activity of SM synthesis n purified myelin. Distribution of plasma-/myelin membrane and Golgi markers 
Marker: SM-synthase"  CNPase b 5"-NT c APDE-I d GP-GalT e Cer-GlcT f 
Myelin PM PM trans-Golgi cis-Golgi 
Homogenate (pmol/mg. h) ~mol/mg. h) (nmol /mg/h)  (nmol /mg/h)  (pmol /mg/h)  (pmol/mg/h) 
(activity) 111 + 11 595 _+ 51 2540 + 73 182 + 7 439 + 10 3209 + 87 
Myelin 
(activity) 235 + 15 3865 + 381 7363 + 111 689 + 13 164 + 12 0 
(R.S.A.) 1 2.1 6.5 2.9 3.8 0.4 0 
(recovery %)2 4.2 19.5 5.7 7.4 0.7 0 
Myelin was isolated and purified [17] and the following enzymes were assayed: phosphatidylcholine:ceramide phosphocholine transferase (SM 
synthase [20], a); 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase, b; a myelin marker); 5'-nucleotidase (5'-NT, c) and alkaline phosphodiesterase- 
I (APDE-I, d) as plasma membrane (PM) markers [21]; UDP-glucose: ceramide glucosyltransferase (CerGlcT, f; cis-Golgi marker); UDP-galactose: 
glycoprotein galactosyltransferase (GP-GalT, e; trans-Golgi marker). GP-GalT activity was measured by a radioassay. The reaction mixture contained 
in a total volume of 100/A: 50 mM Tris-HC1, pH 7.4; 0.5% (v/v) Triton X-100; 10 mM MnC12; 2 mM ATP; 2.0 mg of ovalbumin; 10-50,ug of cellular 
protein; 50/tM of UDP-o-[6-3H]galactose (18.2 Bq/nmol; Amersham Life Science, UK). After 60 min at 37°C, the reaction was stopped with 200 
pl of ice-cold 20% trichloroacetic a id and radioactivity in the washed precipitates was determined. Enzyme assays were carried out in triplicate 
(means -+ SD) and the experiment was replicated twice with similar esults. 
1 R.S.A.: relative specific activity, specific enzyme activity of the purified myelin divided by the specific enzyme activity of the starting homogenate. 
2 %homogenate: he activity found in purified myelin relative to the total activity in the starting homogenate. 
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SM synthesized at the plasma membrane. Table 2 shows that 
with all short-chain labelled C6-Cer precursors approx, half of 
the newly synthesized SM can be back-exchanged. Therefore, 
it is plausible that this pool of SM is made in the external leaflet 
of the plasma membrane. 
3.3. SM synthase activity in myelin and at the plasma membrane 
of cultured oligodendrocytes 
Initial attempts to subfractionate cultured oligodendrocytes 
were in vain because we could not separate plasma membrane 
markers from Golgi markers. Therefore, pure myelin was iso- 
lated, which is an extension of the oligodendroglial p asma 
membrane. If SM synthase is localized at the plasma mem- 
brane, it is likely to be present in myelin as well. Table 3 
indicates that SM synthase activity is indeed found in purified 
myelin. The myelin marker enzyme CNPase [18] was enriched 
6-fold over the homogenate. The enrichment in plasma mem- 
brane markers [21] 5'-nucleotidase (3x)  and alkaline 
phosphodiesterase (4 x ) indicates that the myelin fraction con- 
tained also a significant amount of plasma membrane. Contrar- 
ily, only 0.7% of the total activity of a trans-Golgi marker 
(UDP-galactose:glycoprotein galactosyltransferase) was re- 
covered in the myelin fraction. Moreover, the complete absence 
of the cis-Golgi marker UDP-glucose:ceramide glucosyltrans- 
ferase [20] indicates that Golgi contamination f the myelin 
fraction is negligible. This strongly suggests that SM synthase 
is intrinsic to the myelin membrane and/or plasma membrane 
fraction. 
Our estimate, that about half of the total SM is synthesized 
at the plasma/myelin membranes (Table 2), corroborates previ- 
ous estimates from studies in vivo [8,9]. Oligodendrocytes might 
be unique in this respect, because no other cell type has been 
reported to synthesize such a large proportion of cellular SM 
at the plasma membrane. More than half of myelin-associated 
enzymes are involved in lipid metabolism [30] and the data in 
Table 3 indicate that SM synthase can be added to this growing 
list of lipid metabolizing enzymes in myelin. 
Generally, the bulk of cellular SM resides in the outer leaflet 
of the plasma membrane and is produced by SM synthase in 
the lumen of the Golgi stacks [3,4]. Our data on cultured oli- 
godendrocytes indicate that the plasma nd myelin membranes 
can contribute substantially to SM synthesis. It is interesting 
to note that a distinct pool of SM, probably located at the 
cytosolic face of the plasma membrane [12], has been postulated 
to be involved in signal transduction through the operation of 
the SM cycle [10]. Clearly, the precise topology and physiolog- 
ical roles of SM synthase in myelinating cells remain atopic for 
future investigation. 
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